Literature DB >> 1091207

[Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].

N A Shmelev, L N Shabalova, V P Kolosovskaia.   

Abstract

The aim of the study was comparative investigation of cycloserin and terizidone tolerance by patients with the lung tuberculosis. The investigation procedure included parallel clinical observations and electroencephalographic studies (EEG) using light and sonic stimulation. Sixty six and 26 patients treated with cycloserin and terizidone respectively were observed. The results of the studies showed that by the mechanism of their action on the central nervous system terizidone and cycloserine were similar and increased the general reactivity of the brain. However, terizidone promoted an increase of the activating effect of the ascending part of the reticular formation of the brain stem to a lesser extent than cycloserine. Terizidone in a dose of 0.25 g 3 times a day was well tolerated by the patients with concomitant psycho-neurological impairements.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091207

Source DB:  PubMed          Journal:  Antibiotiki        ISSN: 0003-5637


  3 in total

1.  Steady-state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug-resistant tuberculosis.

Authors:  Mwila Mulubwa; Pierre Mugabo
Journal:  Br J Clin Pharmacol       Date:  2019-07-12       Impact factor: 4.335

2.  Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.

Authors:  Martha L van der Walt; Karen Shean; Piet Becker; Karen H Keddy; Joey Lancaster
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

3.  Cycloserine as a urinary tract antiseptic.

Authors:  P Kaltenis
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.